CD274 and neoplasm: Although this cyclophosphamide therapy regimen was shown to increase PD-L1 expression on the surface of EMT6-CDPP tumor cells, its combination with anti PD-L1 antibody did not show greater efficacy compared to anti-PD-L1 antibody single-agent [180].